Charles River Laboratories And Insightec Announce Five-Year Strategic Collaboration To Leverage Focused Ultrasound Technology For Drug Discovery And Preclinical Development In Neuroscience, Aiming To Improve Efficacy Of Neurological Therapies
Portfolio Pulse from Benzinga Newsdesk
Charles River Laboratories and Insightec have announced a five-year strategic collaboration to utilize focused ultrasound technology in drug discovery and preclinical development for neuroscience. This partnership aims to enhance the efficacy of neurological therapies.
September 04, 2024 | 12:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Charles River Laboratories has entered a strategic partnership with Insightec to use focused ultrasound technology in neuroscience drug discovery and preclinical development. This collaboration could enhance the efficacy of neurological therapies.
The partnership with Insightec is significant for CRL as it involves innovative technology in a growing field of neuroscience. This could lead to advancements in drug discovery and development, potentially improving CRL's market position and financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90